Propofol Affects H/R Induced Alveolar Macrophage Death via TLR4/NF-κB/NLRP3 Signaling Pathway
- 1 March 2023
- journal article
- research article
- Published by American Scientific Publishers in Science of Advanced Materials
- Vol. 15 (3), 392-399
- https://doi.org/10.1166/sam.2023.4434
Abstract
Acute lung injury (ALI) is one of the most common acute and critical diseases in clinic. The main pathological features of ALI are increase of pulmonary Vascular permeability, accumulation of inflammatory cells and pulmonary dysfunction due to diffuse pulmonary edema. At present, it is generally believed that the main pathogenesis of ALI is the uncontrolled inflammatory response in the lung. It has been found that cell death plays an important role in the regulation of inflammatory reaction in acute lung injury. Propofol, a new fast-acting, short-acting intravenous anesthetic, it is known that ALI can be alleviated by inhibiting the release of inflammatory factors and inhibiting the anoxia/reoxygenation-induced autophagy, chemotaxis and oxidative stress in macrophages, however, the mechanism of its role in the death of alveolar macrophage remains unknown. Therefore, the aim of this study was to investigate the role of propofol in alveolar macrophage death and its mechanism through anoxia-reoxygenation induced ALI. NR8383 was alveolar macrophage as anoxia-reoxygenation model. LDH release, CCK-8, Elisa and Western Blot were used to investigate the pathway of propofol through TLR4/NF-κB/NLRP3 signaling pathway, mechanism of inhibition of hypoxia-reoxygenation induced alveolar macrophage death of NR8383. The results showed that propofol decreased the release of LDH and the content of IL-1β and IL-18. In addition, propofol pretreatment reduced the protein expression levels of TLR4 downstream pathways (p65 phosphorylation, NLRP3, cleaved-caspase-1, and GSDMD-N), all of which could be reversed by TLR4 receptor antagonist and NLRP3 receptor inhibitors, it’s causing a decrease in alveolar macrophage activity. The results showed that propofol could significantly reduce anoxia-reoxygenation-induced alveolar macrophage death. Propofol may modulate alveolar macrophage death through TLR4/NF-κB/NLRP3 inflammatory signaling pathway, thereby alleviating anoxia-reoxygenation induced Ali, suggesting that propofol may be a potential drug for the treatment of Ali.Keywords
This publication has 24 references indexed in Scilit:
- Mechanisms of lung ischemia-reperfusion injuryCurrent Opinion in Organ Transplantation, 2016
- The NRAMP1, VDR, TNF-α, ICAM1, TLR2 and TLR4 gene polymorphisms in Iranian patients with pulmonary tuberculosis: A case–control studyInfection, Genetics and Evolution, 2016
- Tissue damage negatively regulates LPS-induced macrophage necroptosisCell Death & Differentiation, 2016
- Regulated cell death and inflammation: an auto-amplification loop causes organ failureNature Reviews Immunology, 2014
- Macrophage heterogeneity in tissues: phenotypic diversity and functionsImmunological Reviews, 2014
- The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membraneScience Signaling, 2014
- Macrophage Activation and Polarization: Nomenclature and Experimental GuidelinesImmunity, 2014
- Macrophage endocytosis of high-mobility group box 1 triggers pyroptosisCell Death & Differentiation, 2014
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membraneProceedings of the National Academy of Sciences of the United States of America, 2010